Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Non-Muscle Invasive Bladder Neoplasms
×
pembrolizumab
×
Clear all
Filters
3
NCT04387461
2024-09-25
CORE-001
CG Oncology, Inc.
Phase 2
Completed
35 enrolled
NCT03167151
2020-07-31
PemBla
University of Oxford
Phase 1/2
Terminated
6 enrolled
12 charts